January 2025
AMCP Foundation P&T Competition 2025 Velsipity Drug Overview
The study drug for the 2025 P&T Competition is VELSIPITY™ (etrasimod). Velsipity is a sphingosine 1-phosphate receptor modulator indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults. This webinar provides an overview of the competition drug for participants.
The deadline for entries to the 2025 National P&T Competition (one entry per pharmacy school) is 11:59 pm EST on Monday, January 20, 2025.
January 2025
AMCP Foundation 2025 Internships Deadline
The deadline for AMCP Foundation 2025 Internships is Friday, January 10, 2025 by 11:59PM.
For more information on internships, visit our AMCP Foundation Internships page. Student pharmacists will gain knowledge of the pharmaceutical industry, health plans, pharmacy benefit management companies, employer sites, a public charity, and professional association management.
March 2025
AMCP Foundation 25th Annual National P&T Competition
AMCP Foundation is celebrating the 25th Anniversary of the Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition at AMCP 2025!
